Study Illuminates the Risks—and the Benefits—of Sun Exposure for Melanoma


Nonburning sun exposure is associated with a reduced risk of melanoma, while sunburns are associated with a doubling of the risk of melanoma

Study Illuminates the Risks and the Benefits of Sun Exposure for Melanoma

Study Illuminates the Risks and the Benefits of Sun Exposure for Melanoma

Although individuals are rightly cautioned about the damaging effects of overexposure to ultraviolet radiation, a recent study published in the Journal of Dermo-Endocrinology argues that the benefits of sunlight should not be overlooked, and sensible exposure to sunlight is a key component to a healthy lifestyle.

“Advising the public to stay out of sunshine is not a smart thing from a public health standpoint, in my opinion,” David G. Hoel, PhD, professor at the Medical University of South Carolina and author of the study said in an interview with Oncology Nursing News.

According to the CDC’s National Health and Nutrition Examination Survey, 32% of Americans have a vitamin D insufficiency. Vitamin D is made in the skin when exposed to sunlight and having sufficient levels has been shown to confer many health benefits, including improved survival rates for breast cancer.

Authors on the study note, in fact, that getting the proper amount of sunlight may actually decrease an individual’s risk for getting melanoma.

“The principal identified nongenetic risk factor is ultraviolet radiation (UVR) exposure, and the relationship between melanoma and UVR is two-sided: nonburning sun exposure is associated with a reduced risk of melanoma, while sunburns are associated with a doubling of the risk of melanoma,” according to the authors: People who work outdoors have a lower incidence of melanoma than those who work indoors, and most melanomas occur on body areas that receive lower amounts of sunlight.

Additionally, the incidence of melanoma has been rising for more than 70 years. While there are many proposed explanations for this, such as the depletion of the ozone layer, diagnostic drift, widespread use of UVR devices, and the proliferation of large windows in office buildings, authors wrote that none of these explanations are particularly satisfactory for the increase of the disease since the 1930s.

“We mention how melanoma incidences have been going up steadily in this country,” Hoel said. “We don't have a good explanation, other than possibly changes in diagnosis but also the movement of people inside.”

However, that does not mean that sun exposure does not pose risks. While sensible and proper sun exposure can be beneficial on many levels, getting too much—leading to sunburn—can be very damaging.

“Just like anything else in life, it’s about moderation,” Michael F. Holick, MD, PhD, professor of Medicine, Physiology and Biophysics at Boston University School of Medicine said, emphasizing that it is important for each individual to know their sun risk and tolerance levels, which include skin tone, how easily a person burns, and the UV index.

To make it easier for individuals to ensure that they are getting the proper and safe amounts of sun exposure each day, Holick and his team created a smartphone app, D Minder, that helps users optimize their sun time by offering outdoor recommendations based on location, body type, and time of the day. The app also warns users when they might be more at risk for sun burn.

“You never want to get a sunburn. That's the most damaging to your skin and increases your risk for melanoma because it's the number of sunburn experiences that have been associated with increased risk,” Holick said.

Overall, the authors expressed that they wish for a change in the recommendations around sunlight exposure.

“I would hope that organizations such as the CDC would modify a little bit what they put out on their website about watching out for sunlight,” Hoel said. “You don’t want kids growing up with a fear of sunshine.”

Related Videos
Ahulwalia on Targeting the Blood Brain Barrier With Novel Immunotherapies and Precision Oncology
Expert Talks Significance of Relatlimab/Nivolumab Approval for Metastatic Melanoma
Newly Approved Tebentafusp Requires Up-Front Active Toxicity Management in Melanoma
Expert Explains Significance of LAG-3 Inhibition in Novel Immunotherapies for Melanoma
 Expert Explains Rationale Behind RELATIVITY-047 in Melanoma
Nurses May Advise Patients on Immunotherapy to Increase Fiber Intake
Diet and Probiotics Influence Immunotherapy Responses in Melanoma
© 2024 MJH Life Sciences

All rights reserved.